- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | CVRx has an activist investor urging it to get acquired | 2 | MassDevice | ||
| Di | CVRx responds to shareholder letter on company valuation | 1 | Investing.com | ||
| Mo | CVRx earns new Medicare Advantage coverage policy for Barostim | 1 | MassDevice | ||
| Mo | CVRx, Inc.: CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy | 1 | GlobeNewswire (USA) | ||
| CVRX Aktie jetzt für 0€ handeln | |||||
| 17.08. | Cantor cuts CVRx stock price target on sales execution challenges | 1 | Investing.com | ||
| 11.08. | CVRx auf der Canaccord Genuity Wachstumskonferenz: Fortschritte bei Kostenerstattung, aber Belastungen im Vertrieb | 1 | Investing.com Deutsch | ||
| 11.08. | CVRx to replace CRO after cutting guidance and DOJ civil inquiry | 1 | MassDevice | ||
| 11.08. | CVRx, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.08. | CVRx forecasts 2026 revenue of $58M-$60M amid sales productivity and medicare advantage headwinds | 1 | Seeking Alpha | ||
| 07.08. | Piper Sandler stuft CVRx-Aktie wegen Vertriebs- und Kostenerstattungsproblemen herab | 1 | Investing.com Deutsch | ||
| 07.08. | Piper Sandler cuts CVRx stock rating on sales, reimbursement issues | 2 | Investing.com | ||
| 07.08. | CVRx Stock Is Falling Overnight: Here's What's Driving the Move | 1 | Benzinga.com | ||
| 07.08. | CVRx GAAP EPS of -$0.53 misses by $0.01, revenue of $15.71M beats by $0.16M | 1 | Seeking Alpha | ||
| 06.08. | CVRx, Inc.: CVRx Reports Second Quarter 2026 Financial and Operating Results | 270 | GlobeNewswire (Europe) | MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| 29.06. | CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? | 1 | Zacks | ||
| 09.06. | CVRx CFO Oasheim To Step Down | 1 | RTTNews | ||
| 09.06. | CVRx CFO Jared Oasheim to step down | 1 | Seeking Alpha | ||
| 09.06. | CVRx, Inc.: CVRx Announces Chief Financial Officer Transition | 310 | GlobeNewswire (Europe) | MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| 03.06. | CVRx, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | CVRx earns Humana Medicare Advantage win for Barostim | 1 | MassDevice |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 2,555 | -3,77 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,220 | +0,83 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| CYTOSORBENTS | 0,288 | -0,69 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,590 | -1,64 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| FULGENT GENETICS | 16,900 | -0,59 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| EMBECTA | 4,390 | +0,62 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ELECTROCORE | 8,500 | 0,00 % | electroCore, Inc.: electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards | ||
| CATHETER PRECISION | 0,203 | +0,25 % | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,560 | +0,06 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| ENVUE MEDICAL | 0,350 | +1,60 % | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 5,250 | +4,90 % | ASP Isotopes Inc.: ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing | Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project Listing expected to provide investors with direct exposure to one of... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,080 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| FEMASYS | 3,210 | +0,31 % | Femasys partners with UNC Health for fertility services | ||
| CUPRINA HOLDINGS | 3,010 | +0,33 % | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| EXAGEN | 6,350 | -2,31 % | Exagen Inc. Reports Second Quarter 2026 Financial Results | Achieved record total revenue, test volume and trailing twelve-month ASP Reduced net loss by nearly 30% and narrowed adjusted EBITDA loss to $0.1 million Increased full-year revenue guidance to... ► Artikel lesen |
CVRX INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,940 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CVRX INC finden Sie auf Wallstreet Online.